The clinical implications of applying the new criteria of acute myocardial infarction (AMI) with cardiac troponins in terms of their diagnostic and prognostic impact in patients with suspected acute coronary syndromes (ACS) have not been well evaluated.
n September 2000, the definition of acute myocardial infarction (AMI) was revised by a joint committee of the European Society of Cardiology and the American College of Cardiology, 1 utilizing new markers for myocardial damage such as cardiac troponin T (TnT) or I. The inclusion of troponins was based on a large body of evidence showing that an elevated troponin concentration correlates with pathologically proved myocardial necrosis and carries a poor prognosis with a positive relationship with mortality in the setting of acute coronary syndromes (ACS). [2] [3] [4] [5] [6] However, the clinical implications of applying the new definition in terms of the diagnostic and prognostic impact in patients with suspected ACS have not been fully evaluated yet except for a couple of studies in Europe 7, 8 and the United States. 9 Because the clinical features and management of ACS are distinct in the absence or presence of ST elevation (STE), we hypothesized that the effect of using cardiac troponins on diagnosis and prognosis would differ between patients with STE and those without it. We therefore carried out an observational study to clarify the diagnostic significance of cardiac TnT and its prognostic role in in-hospital death in patients with ACS with or without STE. We also investigated any remaining role for creatine kinase (CK) as a conventional cardiac marker in predicting in-hospital death, using multiple logistic regression analysis.
Methods

Patient Grouping and Diagnostic Criteria
We studied 977 consecutive patients with ACS who were admitted to the Coronary Care Unit of Nippon Medical School Hospital, Tokyo, between 1999 and 2002. The diagnosis of ACS was based on the presence of (1) acute ischemic symptoms within the preceding 48 h, (2) electrocardiographic (ECG) changes consistent with ACS, and/or (3) serial increases in serum biochemical markers of cardiac necrosis. STE ACS was diagnosed when new or presumed new STE ≥1 mm was seen in at least 2 contiguous leads or new left bundle-branch block was found during the hospitalization. Patients with cardiac arrest on arrival who were suspected to have ACS were excluded from the study. Patients were categorized into 3 groups in terms of significant elevation of CK and TnT: the unstable angina (UA) group included patients with no significant CK elevation and negative TnT; the TnT-myocardial infarction (MI) group included patients with no significant CK elevation but positive TnT (previously diagnosed as "high-risk" UA but now MI by the new definition); the CK- 10 ).
Significant CK elevation was defined as characteristic elevation of serum CK (peak CK >twice the upper limit) with MB fraction at least >10% of total CK. Positive TnT was defined as >0.10 ng/ml, either by whole blood rapid panel test (TROP T sensitive, Roche Diagnostics, Mannheim, Germany) or by a quantitative electrochemiluminescence immunoassay (Elecsys TroponinT STAT III, Roche Diagnostics). 11 The rapid TnT test was performed on admission and ≥4 h later so that one sample was taken at least 6 h after the onset of chest pain. The quantitative estimation of TnT was performed on admission or on the following day. Four patients in the UA group were excluded from analysis because their serum TnT concentrations were not available. If patients initially having UA complicated by MI during the hospital stay, they were classified as having AMI (22 patients). The patients with a recent MI presenting sustained STE within 14 days from onset (diagnosed by development of new pathological Q waves or ST-T changes with elevation of aspartate aminotransferase or lactate dehydrogenase) were included in the STE CK-MI group even when significant CK elevation was unable to be documented. Left ventricular ejection fraction (LVEF) was determined by echocardiography recorded within 24 h after admission in all but 12 patients. Coronary angiography was performed in 902 patients (93%).
Our management strategy for ACS was based on the ACC/AHA guidelines for the management of AMI 12 or non-STE ACS. 2 For patients with STE ACS, primary percutaneous coronary intervention (PCI) was considered as first choice, and for non-STE ACS, an early invasive strategy was selected whenever applicable. All information was collected from the medical records. We compared the clinical characteristics and in-hospital mortality among the 3 groups and performed a multiple logistic regression analysis to identify the independent predictors for in-hospital death. Subgroup analysis was performed because treatment strategy and in-hospital mortality differed between patients with and without STE ACS. The cause of death was classified as 4 types of cardiac death and non-cardiac death. Cardiac death included (1) pump failure resulting in pulmonary edema or cardiogenic shock, (2) cardiac rupture (ventricular free wall rupture and/or ventricular septal rupture), (3) coronary artery bypass grafting-related, and (4) unexpected cardiac arrest. Death from intractable arrhythmias or multiple organ failure caused by severely impaired left ventricular (LV) function was defined as pump failure.
Statistical Analysis
Analyses were performed with StatView software version 5.0 (Abacus Concepts, Calabasus, CA, USA). Baseline characteristics were compared by means of one-way ANOVA for continuous variables, and post hoc comparisons were performed using Bonferroni's correction. Fisher's exact test or the chi-square test was used to compare categorical variables. Data are summarized as mean ± SD. All probability values are 2-tailed, and values <0.05 were considered statistically significant. Multiple logistic regression analysis was performed to identify the independent predictors for in-hospital death. Results are presented as odds ratio and 95% confidence intervals. The variables entered in the model were those with probability values of <0.2 in the univariate analysis between survived and non-survived patients. Fig 1 illustrates the relation between the prespecified diagnosis on admission (ie, ACS with or without STE) and the final diagnosis based on the conventional (using CK) and new criteria (using cardiac TnT) for MI. Of a total of 973 patients with ACS, 547 (56%) had STE and 426 patients (44%) did not. Of the patients with STE ACS, 475 (87%) fell into the CK-MI group, whereas only 40 (7%) and 32 (6%) were in the TnT-MI and UA group, respectively. In contrast, of the 426 patients with non-STE ACS 133 were categorized into CK-MI (31%), 130 to TnT-MI (31%) and 163 to the UA group (38%). Overall, the CK-MI, TnT-MI and UA groups accounted for 63%, 17%, and 20%, respectively, of the total patients. In other words, the new criteria identified an additional 170 patients (TnT-MI group) as AMI (28% increase relative to the CK-MI group), and 76% of them were patients with non-STE ACS.
Results
Diagnostic Impact of the New Criteria for MI
The patients' baseline characteristics, including required management, were compared among the 3 groups separated into the patients with STE ACS (Table 1 ) and in those with non-STE ACS (Table 2 ). There was no significant difference among the groups in age, gender, history of MI or the rate of coronary angiography in either STE and non-STE ACS. Of the patients with STE ACS, intra-aortic balloon pumping (IABP) and PCI in the CK-MI group was significantly more common than for the other 2 groups. The patients had more diseased coronary arteries with lower LVEF, reflecting the greater myocardial damage indicated by TnT or CK. Although the incidence of shock was higher in the CK-MI group, it was not significant. In the patients with non-STE ACS, shock occurred significantly more in the CK-MI group, which was reflected by the more frequent use of IABP. Similar to STE ACS, these patients had more diseased coronary arteries with lower LVEF in the order of the CK-MI, TnT-MI and then the UA group. Mainly in the STE ACS patients, the TnT-MI group had comparable clinical characteristics with the UA group. On the other hand, in the non-STE ACS patients, those in the TnT-MI group had the median clinical characteristics. Fig 2 shows the in-hospital mortality rates in the 3 groups with or without STE. In-hospital death was proportional to the severity of myocardial damage determined by cardiac TnT and CK in both STE and non-STE ACS. However, statistical significance was achieved only in non-STE ACS. Post hoc intergroup comparison revealed that the mortality rate was significantly higher in the CK-MI group than in either the TnT-MI or UA group, suggesting an important role for the conventional CK criteria in predicting prognosis of non-STE ACS.
In-Hospital Mortality and Cardiac Markers
The causes of death in each group were analyzed separately with or without STE (Table 3) . Of the 47 patients with STE ACS who died, 40 (85%) were cardiac deaths. In the non-STE ACS group, 27 of 31 patients (87%) died from cardiac causes. The causes of non-cardiac death included sepsis (n=2), pneumonia (n=2), hemorrhagic shock (n=2), malignancy (n=2), disseminated intravascular coagulation (n=2), and stroke (n=1). Pump failure was a major cause of cardiac death in both STE and non-STE ACS (65% and 85%, respectively). Cardiac rupture occurred only in the CK-MI group with STE. There was no statistically significant difference between any 2 groups with or without STE except for cardiac rupture in the CK-MI group.
Predictors of In-Hospital Mortality
Each of the baseline clinical characteristics was evaluated as a univariate predictor of in-hospital mortality in the patients with STE ACS (Table 4 ). Four variables (high age ≥75 years, presence of shock, low LVEF (<40%) and 3-vessel disease) were shown to be univariate predictors of mortality. When all of the candidate variables were assessed simultaneously in multivariate analysis, these 4 variables remained as significant predictors of in-hospital mortality ( Table 4) .
The same analyses were performed in the patients with non-STE ACS (Table 5 ). Of 7 variables including high age, prior MI, significant CK elevation, positive TnT, presence of shock, low LVEF, and 3-vessel disease, 5 variables remained statistically significant in the multivariate analysis. Of note is that positive TnT was not a significant predictor of mortality whereas significant CK elevation was selected.
Discussion
The present study is a detailed and comprehensive description of the spectrum of ACS patients with or without STE who received the most advanced treatment following recent guidelines. 2, 12 The study demonstrated that an additional 28% of patients were identified as having AMI when the new diagnostic criteria were applied. Using a combination of positive cardiac TnT and significant elevation of CK enabled us to stratify the risk of in-hospital death in both STE ACS and non-STE ACS patients. Moreover, in multiple logistic regression analysis, significant CK elevation remained an independent predictor of in-hospital death in non-STE ACS. These findings suggest that the implementation of the new definition for MI has greater clinical significance in patients with non-STE ACS and that the conventional criteria still play an important role in the diagnosis and risk stratification of ACS.
Diagnostic Impact of the New Criteria for MI
The new definition of MI emphasizes the role of more sensitive and specific markers of myocardial necrosis such as cardiac TnT or TnI, thereby aiming at improving the diagnosis in patients with minimal myocardial necrosis that might be missed by the conventional criteria. 13 Accordingly, it is expected that, by adopting the new criteria, a substantial proportion of ACS patients who used to be diagnosed as UA will be diagnosed as having MI. Indeed, a couple of studies have tested the diagnostic and prognostic implications of the new criteria in patients with ACS. A Finnish study 8 reported that the number of cases of MI increased by 23% compared with those by epidemiologic diagnosis when the diagnosis was primarily based on TnT (>0.10 ng/ml). A study in the United States 9 showed that in 275 patients with AMI, 224 matched the old criteria and 51 matched the new criteria (23% increase). Likewise, another study in the UK 7 reported that the new criteria for MI identified an additional 27% cases of infarct. These results are consistent with our findings in a Japanese cohort (28% increase).
As mentioned earlier, the clinical features and management of ACS differ according to the presence or absence of STE, and the implication of applying the new definition would also be different. However, no previous studies have fully clarified this point although its greater clinical significance in non-STE ACS was suggested by a European study. 14 In the present study, 170 of 365 (47%) patients with UA (by the conventional criteria) were TnT positive. Importantly, 76% of them had non-STE ACS, in keeping with the significant role of TnT in categorizing patients with non-STE in terms of in-hospital death (Fig 2) . However, in the STE ACS patients also, the use of TnT helped subdivide them in order of in-hospital mortality, but they accounted for only 24% of the additional patients diagnosed as having MI.
Reappraisal of the Role of the Conventional CK Criteria for MI
Using the new definition for MI raises the question of whether the conventional CK criteria is useful any more. In general, the technique of measuring CK is very quick, practical, more widely used and cost-effective. Rapid assessment of cardiac troponins can only be done with the whole blood panel test, which usually takes more than a day for quantitative analysis. Moreover, this technique is still not popular, even in the developed countries; for instance, in 9,538 patients of the Euro Heart Survey of Acute Coronary Syndromes, 14 troponin assays were performed in 63.3%, which suggests that many physicians who attend ACS patients are either unaware of or have not accepted the new criteria.
Boersma et al described that, in patients with ACS without persistent STE, elevated CK is an independent predictor of in-hospital death in concurrence with age, heart rate, systolic blood pressure, ST depression, and signs of heart failure. 15 In addition, a recent study showed that significant elevation of CK on admission is highly predictive for cardiac death, and that simple stratification using the most widely available parameters, such as the ST deviation and elevated CK, may be extremely useful. 16 In the present study, the univariate analysis included both significant elevation of CK (>twice the upper limit) and cardiac TnT (>0.10 ng/ml) as significant variables for in-hospital death in patients with non-STE ACS. It is worth noting that multivariate analysis selected significant CK elevation rather than positive TnT as an independent predictor of inhospital death. Although elevated CK was not selected as a predictor of in-hospital death in patients with STE ACS, inhospital mortality tended to be higher in proportion to the severity of myocardial damage determined by TnT and CK (p=0.06). Therefore, it seems reasonable to retain the CK criteria in conjunction with the cardiac troponin for risk stratification of patients with ACS. 
In-Hospital Mortality
In the present study, the in-hospital mortality of patients with STE ACS was comparable with other reports; 12, 17 however, that of non-STE ACS was substantially higher and may be explained at least in part by patient selection bias. First, we had more patients with cardiogenic shock than the other studies. In large clinical trials, the proportion of patients with shock was approximately 5% among STE MI and approximately 4% among those with non-STE MI, 17 whereas the corresponding values in our study were 8.7% among those with STE and 11.3% among those with non-STE. Second, patients at low risk (commonly Braunwald class I with non-STE) were managed in either a general or outpatient ward, without admission to the coronary care unit, so our patient group inevitably included patients at higher risk. Third, the higher proportion of non-cardiac deaths in our study may affect the result. The present study has a non-cardiac death rate of 14%, whereas the study by Hiramori et al 18 reported only 9.5%, which suggests that our patient group included more complicated cases of higher age.
Social Implications of the New Definitions of MI
In addition to increasing the number of patients being diagnosed with MI, the new definition has social implications. The lower diagnostic threshold for MI will have a considerable impact upon patients and their families. A diagnosis of MI may affect the patients' ability to retain or regain employment, with consequences for productivity and health insurance. Thus, the community needs to be informed that the prognosis of patients who have had a small rise in TnT (often without significant CK elevation) is usually excellent, provided that appropriate medical care is given according to the recent guidelines. We believe that, after introduction of the concept of ACS, a paradigm shift has occurred in diagnosing MI, from corroborating myocardial necrosis (by CK or ECG) to stratifying risk of patients with a wide range of myocardial damage including microinfarction that is precipitated by a common mechanism.
Study Limitations
This was an observational study carried out in a single center and some patients had missing hemodynamic data, particularly the severe cases complicated by shock or hemodynamic instability. In addition, the data may have been biased (referral and selection biases). Therefore, one should interpret the results with caution. Furthermore, elevated cardiac markers are only one of many components in the risk stratification of ACS. The optimal risk stratification strategy involves the patient's clinical presentation, physical examination, laboratory and ECG data, and noninvasive and/or invasive investigations. Our study did not fully evaluate that strategy.
